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Introduction
Heat shock proteins (HSPs) are molecular chaperones that use 
ATP hydrolysis to aid the folding of nascent polypeptides, main-
tain proteins in unstable conformations, and prevent protein 
denaturation. These functions are essential in many biological 
contexts, including assembly of macromolecular complexes, 
protein trafficking, and regulation of enzyme activity (Bukau 
et al., 2006). HSPs are particularly important in cells subject 
to proteotoxic stress and are attracting considerable interest 
as potential targets for cancer therapy (Powers and Workman, 
2007; Jego et al., 2013). The Hsp70 proteins represent a major 
family of HSPs that are frequently overexpressed in human can-
cers (Rohde et al., 2005; Daugaard et al., 2007; Kampinga and 
Craig, 2010). Their overexpression correlates with poor prog-
nosis and drug resistance, whereas blocking Hsp70 function 
gives a therapeutic response in tumor models (Nylandsted et al., 
2000; Schmitt et al., 2006; Leu et al., 2009; Massey et al., 2010; 
Powers et al., 2010; Rérole et al., 2011; Balaburski et al., 2013; 
Murphy, 2013).
In humans, there are eight canonical members of the Hsp70 
family, as well as more distantly related members such as Hsp110 
(Rohde et al., 2005; Daugaard et al., 2007). Some are expressed 
in a constitutive manner, such as Hsc70 (encoded by the HSPA8 
gene), whereas others are induced upon stress, such as Hsp72 (en-
coded by the HSPA1A gene). Rapidly dividing cancer cells fre-
quently express high levels of both Hsc70 and Hsp72 as a result of 
oncogenic stress. Although some Hsp70 proteins are restricted to 
membranous compartments, such as Grp78/BiP in the endoplas-
mic reticulum and Grp75/mortalin in the mitochondria, Hsc70 and 
Hsp72 are present throughout the cytoplasm and nucleus. Hsp70 
proteins also associate with the microtubule (MT) cytoskeleton, 
including the mitotic spindle, although to date, their only described 
function at this site is in protecting spindle pole integrity after heat 
shock (Liang and MacRae, 1997; Mack and Compton, 2001; 
Hut et al., 2005; Sauer et al., 2005; Elsing et al., 2014).
Hsp70 proteins represent a family of chaperones that regulate cellular homeostasis and are required for cancer cell survival. However, their function 
and regulation in mitosis remain unknown. In this paper, 
we show that the major inducible cytoplasmic Hsp70 
isoform, Hsp72, is required for assembly of a robust 
bipolar spindle capable of efficient chromosome congres-
sion. Mechanistically, Hsp72 associates with the K-fiber– 
stabilizing proteins, ch-TOG and TACC3, and promotes 
their interaction with each other and recruitment to spin-
dle microtubules (MTs). Targeting of Hsp72 to the mitotic 
spindle is dependent on phosphorylation at Thr-66 within 
its nucleotide-binding domain by the Nek6 kinase. Phos-
phorylated Hsp72 concentrates on spindle poles and 
sites of MT–kinetochore attachment. A phosphomimetic 
Hsp72 mutant rescued defects in K-fiber assembly, ch-
TOG/TACC3 recruitment and mitotic progression that 
also resulted from Nek6 depletion. We therefore propose 
that Nek6 facilitates association of Hsp72 with the mi-
totic spindle, where it promotes stable K-fiber assembly 
through recruitment of the ch-TOG–TACC3 complex.
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Results and discussion
Hsp72 is a novel mitotic substrate  
of the Nek6 kinase
To search for novel Nek6 substrates involved in spindle assem-
bly, two approaches were used: a kinase substrate–tracking and 
elucidation (KESTREL) assay, which identifies proteins in 
fractionated cell extracts that act as excellent substrates for re-
combinant kinases in vitro (Cohen and Knebel, 2006), and a 
coprecipitation assay. The KESTREL screen identified Hsp72, 
-tubulin, and actin as proteins that cofractionated through mul-
tiple steps of purification and were strongly phosphorylated by 
Nek6 (Fig. 1 A and Fig. S1). Hsp72 was also identified in Flag-
Nek6 immunoprecipitates (IPs) prepared from mitotic cells and 
was strongly phosphorylated upon addition of ATP (Fig. 1 B). 
Several members of the NEK protein kinase family con-
tribute to mitotic progression (O’Connell et al., 2003; Quarmby 
and Mahjoub, 2005; Moniz et al., 2011; Fry et al., 2012). One 
of these is Nek6, which plays an essential role in spindle assem-
bly and cytokinesis (Yin et al., 2003; O’Regan and Fry, 2009). 
Phosphorylation by Nek6 targets the Eg5/Kif11 motor protein 
to spindle MTs to promote centrosome separation (Rapley et al., 
2008). However, this alone is unlikely to explain the fragile spin-
dles and mitotic arrest that arise from blocking Nek6 function. 
Here, we show that Hsp72 is a novel mitotic substrate of Nek6 
and that together these proteins play an essential role in assem-
bly of robust mitotic spindles capable of efficient chromosome 
congression through K-fiber (kinetochore fiber) recruitment of 
the ch-TOG (colonic and hepatic tumor overexpressed protein) 
and TACC3 complex.
Figure 1. Nek6 interacts with and phosphorylates Hsp72. (A) KESTREL analysis of HEK 293 cytosolic extracts. Substrate-containing Superdex 200 frac-
tions 3–7 were pooled, incubated with or without Nek6 and -[32P]ATP, and analyzed by Coomassie blue stain (CB) and autoradiography (32P). (B) Flag IPs 
were prepared from HEK 293 cells transfected with Flag-Nek6 and synchronized in S or M. As controls, asynchronous cells (As) transfected with Flag-Nek6 
were subject to IP with rabbit IgGs or no antibodies (Ab). IPs were incubated with -[32P]ATP before analysis by Coomassie blue stain and autoradiography 
(32P). Lines have been added to top blots to indicate where intervening lanes were spliced out for presentation purposes. In A and B, molecular masses 
(kilodaltons) and proteins identified by mass spectrometry are indicated. (C) HEK 293 cells were transfected with wild-type (WT) or catalytically inactive 
(K75M and K64M) Flag-Nek6 or -Nek7 for 24 h before synchronization in S or M. Flag IPs were analyzed by Western blotting with the antibodies indi-
cated. (D) Lysates (inputs), Hsp72 IPs, and IPs prepared with rabbit IgGs from asynchronous, S-phase, or M-phase arrested HEK 293 cells were analyzed 
by Western blotting with the antibodies indicated. (E) Schematic representation of Nek7, Nek6, and Nek6-NTE. N, N terminus; C, C terminus. (F) In vitro 
kinase assays using purified wild-type Nek6, Nek6-NTE, or no kinase with -casein and Hsp72 protein substrates in the presence of -[32P]ATP. 
(G) Substrate phosphorylation was quantified by scintillation counting of dried gels shown in F. Error bars show means ± SD.
351Control of K-fiber assembly by Hsp72 and nek6 • o’regan et al.
N-terminal extensions of these two kinases dictate their sub-
strate specificity at least in the context of the full-length proteins 
(Richards et al., 2009; Vaz Meirelles et al., 2010). It also con-
firms that Nek6 and Nek7 almost certainly play distinct roles 
in cell division (O’Regan and Fry, 2009).
Hsp72 is required for spindle assembly  
and chromosome congression
To determine what function Hsp72 may have in mitotic progres-
sion in the absence of heat shock, it was depleted for 72 h with 
two independent siRNAs (Fig. S2 B) or inhibited for 4 h with 
the ATP-competitive small molecule, VER-155008 (Massey 
et al., 2010). HeLa cells were used for these experiments as 
they express high levels of Hsp72 (Rohde et al., 2005). Time-
lapse imaging of EGFP–lamin A and H2B-mCherry revealed 
that depletion or inhibition of Hsp72 did not interfere with 
Hsp72, identified using antibodies that do not cross-react with 
Hsc70 (Fig. S2 A), coprecipitated with wild-type and catalyti-
cally inactive Nek6 from S- and M-phase cells but not with the 
closely related Nek7 kinase (Fig. 1 C). In contrast, both Nek6 
and Nek7 coprecipitated with their upstream activator, Nek9 
(Roig et al., 2002).
Endogenous Nek6, but not Nek7, also coprecipitated with 
Hsp72, indicating that this interaction was not a result of Nek6 
overexpression. Indeed, Nek6 coprecipitated more efficiently from 
cells arrested in M than S phase (Fig. 1 D). As Nek6 and Nek7 
differ significantly only in the short (30–40 amino acid) exten-
sions N-terminal to the catalytic domains, a Nek6 truncation 
mutant lacking this N-terminal extension (Nek6-NTE) was 
generated (Fig. 1 E). Although retaining significant activity 
against -casein, truncated Nek6 barely phosphorylated Hsp72 
(Fig. 1, F and G). This agrees with previous suggestions that the 
Figure 2. Hsp72 promotes chromosomes congression and mitotic progression. (A) HeLa:EGFP–lamin A/mCherry-H2B cells were either mock-depleted, 
depleted with siRNAs against Hsp72 for 72 h, or treated with Hsp70i for 4 h, as indicated, before time-lapse imaging. Stills from representative videos 
are shown with times (minutes) from mitotic entry indicated. (B and C) Quantification of cells from A indicating the time from NEBD to last chromosome 
congressed (B) and last chromosome congressed to anaphase onset (C). Data represent cumulative frequencies (±SD). (D) HeLa cells were mock depleted, 
depleted of Hsp72 for 72 h, or treated with Hsp70i for 4 h, as indicated, and then processed for IF with -tubulin and CENP-A antibodies. (E) Total spindle 
MT intensity of cells in D was plotted relative to that of mock-depleted cells. *, P < 0.05. (F) HeLa cells treated as in D before IF with -tubulin antibodies; 
enlargements show spindle pole regions. (G) Distance between spindle poles in the z axis of HeLa cells treated as in D. For box and whisker plots, boxes 
represent the 25th and 75th percentile, the green and white lines represent the medians and means, respectively, and whiskers show the 10th and 90th 
percentiles. (H) HeLa cells stably expressing mCherry-H2B were arrested in mitosis for 4 h with MG132. Time-lapse imaging was used to follow metaphase 
plate alignment with times (minutes) from addition of DMSO or Hsp70i as indicated. In D and F, DNA was stained with Hoechst 33258. Data are means 
(±SD) of 100–300 cells. Bars: (A, D, F [right], and H) 10 µm; (F, left) 2 µm.
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orientation from the horizontal plane were also indicative of 
defective spindle–cortex attachment (Fig. 2, D, F, and G). Ad-
dition of the Hsp70 inhibitor to preformed spindles assembled 
in MG132-arrested mitotic cells led to release of chromosomes 
from the metaphase plate, indicating that Hsp70 is required to 
maintain, as well as establish, chromosome alignment (Fig. 2 H 
and Videos 4 and 5). Staining for the spindle assembly check-
point protein, BubR1, revealed intense kinetochore staining 
upon either depletion or inhibition of Hsp72 (Fig. S2, D and E). 
Hence, Hsp72 is essential for HeLa cells to generate a robust 
mitotic spindle capable of cortical attachment, chromosome 
congression, and satisfaction of the spindle assembly check-
point. Although the phenotypes of Hsp72 depletion and Hsp70 
inhibition were remarkably similar, some differences were noted 
(e.g., more consistent displacement of spindle orientation in 
chromatin condensation or nuclear envelope breakdown (NEBD). 
However, it strongly perturbed chromosome congression and 
anaphase onset (Fig. 2 A, Fig. S2 C, and Videos 1–3). In some 
cells, chromosomes rapidly detached from the metaphase plate, 
whereas in others, chromosomes failed to congress. Quantifica-
tion confirmed that depletion or inhibition of Hsp72 extended 
the time in prometaphase by delaying the time from NEBD to 
last chromosome congressed and, in metaphase, by delaying 
the time from last chromosome congressed to anaphase onset 
(Fig. 2, B and C).
Staining of fixed cells with -tubulin and CENP-A anti-
bodies after either depletion or inhibition of Hsp72 revealed the 
presence of poorly organized spindles with reduced MT den-
sity (Fig. 2, D and E). A shortened interpolar distance, fewer 
astral MTs in the vicinity of poles and displacement of spindle 
Figure 3. Hsp72 promotes recruitment of ch-TOG–TACC3 complexes to K-fibers. (A) HeLa cells treated as indicated were placed on ice for 10 min before 
IF with -tubulin and CENP-A antibodies to reveal K-fibers. (B) K-fiber intensity is plotted relative to that in mock-treated cells. (C) HeLa cells treated as indi-
cated were incubated with 50 µM monastrol for 4 h, placed on ice for 10 min, and then processed for IF with -tubulin and CENP-A antibodies. (D) The 
length of K-fibers in the monopolar spindles is plotted. For box and whisker plots, boxes represent the 25th and 75th percentile, the green and white lines 
represent the medians and means, respectively, and whiskers show the 10th and 90th percentiles. (E and F) HeLa cells treated as indicated were processed 
for IF with antibodies against -tubulin and ch-TOG (E) or TACC3 (F). (G and H) The intensity of ch-TOG (G) and TACC3 (H) relative to tubulin from cells 
in E and F is indicated. (I) K-fiber intensities were measured as in B after Hsp72 or mock depletion and expression of siRNA-resistant Hsp72 constructs. 
siMock, mock siRNA; WT, wild type. (J) Hsp72 IPs were prepared from mitotic cells treated with or without Hsp70i and analyzed by Western blotting with 
the antibodies indicated. (K) The amount of proteins precipitated in J is quantified relative to that in DMSO-treated Hsp70 IPs. (L) Flag IPs prepared from 
mitotic cells induced to express Flag-TACC3 with doxycycline and treated with Hsp70i were analyzed by Western blotting for Flag, Hsp72, and ch-TOG. 
(M) The amount of proteins precipitated in L is quantified relative to DMSO-treated Flag IPs. In A, C, E, and F, DNA was stained with Hoechst 33258. Data 
are means (±SD) of 100–300 cells. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bars, 10 µm.
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Sauer et al., 2005), Hsp72 antibodies stained spindle MTs in 
HeLa cells, particularly in the vicinity of spindle poles in early 
mitosis before concentrating at the midbody in late mitosis 
(Fig. 4 F). This staining was lost upon Hsp72 depletion (Fig. S2 
H). Recombinant wild-type and catalytically inactive (K71E) 
Hsp72 proteins also localized to spindle MTs in HEK 293 cells, 
indicating that catalytic activity is not required for spindle as-
sociation (Fig. 4 G). The pHsp70 antibody revealed no staining 
of interphase cells, consistent with low Nek6 activity outside 
of mitosis but strongly stained spindle poles and sites of MT– 
kinetochore attachment in metaphase cells (Fig. 4 H). Again, 
this staining was lost upon depletion of Hsp72 (Fig. S3 D). Close 
inspection revealed spatially distinct localization of pHsp70 
and the inner kinetochore marker, CenpA, but strong coherence 
with the outer kinetochore marker, CenpE (Fig. 4 I). Together 
with the presumed defects in spindle–cortex attachment seen 
upon loss of Hsp72 function, this might suggest additional, 
as-yet-undetermined, roles in attachment of MT plus ends to 
kinetochores and the cortex. Strikingly, depletion of Nek6 led 
to loss of Hsp72 from the mitotic apparatus that was above and 
beyond the reduced MT density that results from Nek6 deple-
tion (Fig. 4, J and K). We therefore conclude that phosphory-
lation by Nek6 contributes to spindle localization of Hsp72 
during mitotic progression.
A phosphomimetic Hsp72 mutant  
can rescue mitotic defects caused by  
Nek6 depletion
To determine whether the mitotic progression defects seen 
upon Nek6 depletion (Yin et al., 2003; O’Regan and Fry, 2009) 
might result from failure to phosphorylate Hsp72, wild-type 
and mutant Hsp72 proteins were expressed in cells from which 
Nek6 had been depleted (Fig. S2 I). Wild-type Hsp72 and the 
T66A mutant were unable to rescue the increase in mitotic 
index induced by Nek6 depletion; however, this was rescued 
by Hsp72-T66E (Fig. 5 A). Interestingly, expression of the 
T66A mutant in mock-depleted cells led to a twofold increase 
in the mitotic index, and microscopic analysis revealed a signif-
icant increase in multinucleated cells and cells with chromatin 
bridges and micronuclei indicative of mitotic failure (Fig. 5 B). 
K-fiber intensities and spindle recruitment of ch-TOG and 
TACC3 were also reduced in Nek6-depleted cells in a manner 
similar to that seen upon Hsp72 depletion (Fig. 5, C–H). This 
reveals for the first time that Nek6 contributes to K-fiber stabil-
ity and ch-TOG/TACC3 recruitment. Moreover, Hsp72-T66E, 
but not wild-type Hsp72, could rescue the loss of K-fibers 
and ch-TOG/TACC3 recruitment in Nek6-depleted cells. In 
contrast, the T66A mutant failed to effectively localize to the 
spindle and exacerbated the K-fiber and ch-TOG/TACC3 re-
cruitment defect in cells depleted of Nek6. It was also unable to 
rescue the K-fiber defect seen upon Hsp72 depletion (Fig. 3 I). 
We therefore conclude that Hsp72 represents an important new 
target of Nek6 and that Nek6 function in spindle assembly is, 
at least in part, exerted through phosphorylation of Hsp72.
This study identifies Hsp72 as an essential regulator of 
cancer cell division. HSP inhibitors are being developed as an-
ticancer drugs with Hsp90 inhibitors in advanced clinical trials 
Hsp70-inhibited cells; Fig. 2 G). This might reflect additional roles 
in mitosis for other Hsp70 isoforms inhibited by VER-155008.
Hsp72 promotes assembly of the  
ch-TOG–TACC3 complex and its 
recruitment to K-fibers
The chromosome congression defect points toward a failure 
to generate stable K-fibers, the MT bundles that attach spindle 
poles to kinetochores. Consistent with this, depletion or inhibi-
tion of Hsp72 led to a decrease in K-fiber intensity as visible in 
cold-treated cells (Fig. 3, A and B). Furthermore, K-fiber length 
in monopolar spindles assembled in the presence of the Eg5 
inhibitor, monastrol, was reduced in the absence of functional 
Hsp72 (Fig. 3, C and D). To explore how Hsp72 might regulate 
K-fiber stability, localization of the ch-TOG and TACC3 pro-
teins that contribute to inter-MT bridges in K-fibers was exam-
ined (Booth et al., 2011). Intriguingly, blocking Hsp72 function 
led to loss of both proteins from the mitotic spindle (Fig. 3, 
E and F). This loss of K-fiber association was greater than loss 
of K-fibers themselves, as revealed by measuring abundance 
relative to tubulin (Fig. 3, G and H), and could be rescued by 
expression of RNAi-resistant Hsp72 (Fig. 3 I and Fig. S2 F). 
K-fiber association of ch-TOG and TACC3 depends on their 
assembly into a complex that also includes clathrin (Hood 
et al., 2013). Endogenous Hsp72 coprecipitated from mitotic 
cells with TACC3 and ch-TOG but not the spindle-associated 
Cep55, whereas their association with Hsp72, but not their expres-
sion, was diminished upon loss of Hsp70 function (Fig. 3, J and K; 
and Fig. S2 G). Moreover, interaction between Flag-TACC3, 
expressed in doxycycline-inducible cells, and both Hsp72 and 
ch-TOG was perturbed in mitotic cells by the Hsp70 inhibitor 
(Fig. 3, L and M). Thus, we propose that Hsp72 contributes to 
robust spindle assembly through promoting ch-TOG–TACC3 
complex formation and K-fiber recruitment, although we do not 
rule out additional roles in spindle MT assembly or stability.
Phosphorylation by Nek6 targets Hsp72 
to the mitotic spindle
To determine how Nek6 regulates Hsp72, the endogenous 
Hsp72 protein purified in the KESTREL screen was incubated 
with Nek6 in vitro and subjected to mass spectrometry. This 
identified Thr-66, which lies within the N-terminal nucleotide-
binding domain and is conserved across the human Hsp70 iso-
forms, as a major phosphorylation site (Fig. 4 A and Fig. S3, 
A and B). Mutation of this site to alanine (T66A) led to sub-
stantial loss of phosphorylation by Nek6 in vitro (Fig. S3 C). 
A phosphospecific antibody (pHsp70) generated against this 
site detected recombinant wild-type Hsp72, but not a T66A 
mutant, after incubation with Nek6 (Fig. 4 B). Western blotting 
with the pHsp70 antibody of IPs prepared with Hsp72 antibod-
ies demonstrated that both endogenous and recombinant Hsp72 
were phosphorylated on this site in mitosis, whereas pHsp70 
reactivity was lost in cells depleted of Nek6 (Fig. 4, C–E). 
Hence, we conclude that Hsp72 is phosphorylated on Thr-66 in 
a mitosis-specific and Nek6-dependent manner.
Consistent with identification of Hsp70 proteins in puri-
fied human spindle preparations (Mack and Compton, 2001; 
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Figure 4. Nek6 phosphorylation targets Hsp72 to the mitotic spindle. (A) Schematic representation of Hsp72 showing nucleotide (NBD) and substrate 
(SBD) binding domains and sequence alignment of the human Hsp70 family around threonine-66. Bold indicates conserved residues. N, N terminus; 
C, C terminus. (B) Purified Hsp72 wild-type (WT) or T66A proteins incubated with or without purified Nek6 were subjected to Western blotting with total 
Hsp70 and Hsp70-pT66 (pHsp70) antibodies (C) HEK 293 cells were either untransfected (lane 1) or transfected with Flag-Hsp72 wild type (lanes 2–4) 
and left asynchronous (As) or synchronized at S or M before immunoprecipitation with Flag antibodies. Lysates and Flag IPs were analyzed by Western 
blotting with Flag and pHsp70 antibodies. (D) Lysates and Hsp72 IPs from HEK 293 cells that were either asynchronous or synchronized in different cell 
cycle stages were analyzed by Western blotting as indicated (pHH3, phospho–histone H3). (E) Lysates and Hsp72 IPs from HEK 293 cells transfected with 
Nek6, Nek7, or GAPDH siRNAs were analyzed by Western blotting as indicated. (F) HeLa cells were processed for IF with -tubulin and Hsp72 antibod-
ies. (G) HEK 293 cells transfected with GFP-tagged wild-type and catalytically inactive (K71E) Hsp72 were analyzed by IF with -tubulin (red) and GFP 
(green) antibodies. (H and I) HeLa cells were processed for IF with pHsp70 and -tubulin, CenpA, or CenpE antibodies, as indicated. In I, zoomed-in views 
of kinetochores are shown on the right from the boxed regions in the cells on the left. (J) HeLa cells were mock- or Nek6-depleted before IF with Hsp72 
and -tubulin antibodies. (K) The intensity of Hsp72 at metaphase spindle poles was quantified relative to -tubulin. In F–J, DNA was stained with Hoechst 
33258 (blue). siMock, mock siRNA. Bars: (F–I [left images] and J) 10 µm; (I, right images) 0.5 µm.
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Figure 5. Hsp72-T66E rescues mitotic defects that arise upon Nek6 depletion. (A) HeLa cells were mock or Nek6 depleted for 48 h before transfection with 
Flag-Hsp72 constructs as indicated for 24 h and IF with Flag and phospho-H3 antibodies. The mitotic index of transfected cells was counted by microscopic 
analysis of chromatin. (B) HeLa cells transfected with Flag-Hsp72 constructs indicated for 24 h were stained with Flag and -tubulin antibodies and scored 
by IF for the occurrence of nuclear defects. Data in A and B are means (±SD) of 100–300 cells. (C) HeLa cells were treated as in A, placed on ice for 
10 min, and analyzed by IF with antibodies against -tubulin to reveal K-fibers (green) and Flag to detect transfected cells. (D) Total K-fiber intensity from 
C is plotted relative to that in mock-treated samples. (E and F) HeLa cells were treated and processed as in C but with ch-TOG (E) and TACC3 (F) antibodies. 
(G and H) Total ch-TOG and TACC3 intensity from E and F is plotted relative to that in mock-treated samples. Error bars show means ± SD. In C, E, and 
F, DNA was stained with Hoechst 33258 (blue). siMock, mock siRNA; WT, wild type. *, P < 0.05. Bars, 10 µm.
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N-terminal Flag tag from a constitutive cytomegalovirus promoter in mam-
malian cells. They were also subcloned into the pTWO-E plasmid, expressed 
as His fusions from a T7 promoter, and purified on 5-ml HisTrap columns 
(GE Healthcare); columns were washed with 50 mM imidazole, and pro-
tein was eluted on a gradient of 50–500 mM imidazole. The eluted protein 
was dialyzed against 20 mM Tris, pH 8.0, 100 mM NaCl, and 5 mM 
-mercaptoethanol and passed over a 5-ml Q Sepharose column to re-
move contamination by the Escherichia coli Hsp70 homologue DnaK. The 
Q column flow-through was dialyzed into 100 mM Tris, pH 7.5, 150 mM 
NaCl, 6 mM MgCl2, and 10% glycerol and concentrated to 5 mg/ml. 
The absence of DnaK from Hsp70 samples was confirmed by Western 
blotting with SPA-880 mouse antibody (Enzo Life Sciences). Flag-Nek6 
and Flag-Nek7 plasmids are as previously described (O’Regan and Fry, 
2009). In brief, full-length cDNAs of Nek6 and Nek7 were subcloned 
into the pFLAG-CMV2 vector as PCR fragments using NotI and XbaI sites. 
Flag-TACC3 was inserted into pTre2Hyg by subcloning a Flag-TACC3 
PCR fragment with NheI and NotI sites. Mutations were introduced using 
the GeneTailor Site-Directed Mutagenesis System (Invitrogen), and all con-
structs were confirmed by Sanger sequencing.
Cell culture, synchronization, and transfection
HeLa and HEK 293 cells were grown in DMEM (Invitrogen) supplemented 
with 10% heat-inactivated FBS, 100 IU/ml penicillin, and 100 µg/ml strep-
tomycin at 37°C in a 5% CO2 atmosphere. For inducible expression of 
Flag-TACC3, TetOn HeLa cells (Takara Bio Inc.) were used. TetOn HeLa 
cells with stably integrated pTRE2hyg-Flag-TACC3 plasmid were main-
tained with 300 µg/ml G418 and 200 µg/ml Hygromycin B. Expression 
of Flag-TACC3 was induced with 0.5 µg/ml doxycycline, 24 h before 
analysis. Cells were synchronized in S phase by incubation for 16 h with 
either 1 mM hydroxyurea or 2 mM thymidine. M-phase arrested cells were pre-
pared by shake-off after 16 h treatment with either 50 ng/ml nocodazole 
or 100 µM monastrol. For G1 cells, a mitotic population was collected as 
described for M phase–arrested cells and replaced into fresh medium for 
6 h. G2 cells were obtained by placing thymidine-treated cells into fresh 
medium for 8 h. Synchronization was confirmed by flow cytometry. To re-
veal K-fibers, synchronized cells were replaced into chilled media and incu-
bated on ice for 10 min before methanol fixation. For IPs from mitotic cells, 
nocodazole was washed out, and cells were replaced into fresh media 
for 45 min to allow spindle MTs to form before cell lysis. Transient trans-
fections were performed with FuGENE HD reagent (Promega) according 
to manufacturer’s instructions, and cells were transfected for 24 h, unless 
stated otherwise. To inhibit Hsp70, cells were treated with 5 µM VER-
155008 (Tocris Bioscience) for 4 h; control cells were treated with the same 
volume of DMSO. To depolymerase MTs, cells were incubated with 3 µM 
nocodazole for 4 h. HeLa-EGFP-LaminA/mCherry-H2B cells were provided 
by J. Ellenberg (European Molecular Biology Laboratory, Heidelberg, 
Germany) and grown in DMEM supplemented with 10% FBS, 500 µg/ml 
G418, and 0.5 µg/ml puromycin.
Fixed and live-cell microscopy
Cells grown on acid-etched glass coverslips were fixed with ice-cold metha-
nol and processed as previously described (O’Regan and Fry, 2009). In 
brief, media were aspirated, and cells were fixed by incubation in ice-cold 
methanol at 20°C for a minimum of 10 min. Cells were then blocked 
in PBS supplemented with 3% BSA before incubation with the appropri-
ate antibody diluted as required in PBS supplemented with 3% BSA. For 
Hsp72 staining, cells were preextracted for 30 s (60 mM Pipes, 25 mM 
Hepes, pH 7.4, 10 mM EGTA, 2 mM MgCl2, and 1% Triton X-100) be-
fore methanol fixation, whereas for ch-TOG and TACC3 staining, cells 
were fixed in 3.7% formaldehyde and permeabilized with 0.5% Triton 
X-100. Primary antibodies were 1 µg/ml mouse Hsp72 (Enzo Life Sci-
ences), 0.3 µg/ml mouse -tubulin (Sigma-Aldrich), 2 µg/ml rabbit 
-tubulin (Abcam), 0.5 µg/ml mouse Flag (Sigma-Aldrich), 2 µg/ml mouse 
phospho–histone H3 (EMD Millipore), 2 µg/ml mouse CenpA (Abcam), 
1 µg/ml rabbit ch-TOG (Bethyl Laboratories, Inc.), 2 µg/ml mouse TACC3 
(Abcam), 1 µg/ml mouse BubR1 (EMD Millipore), 0.5 µg/ml rabbit GFP 
(Abcam), 1 µg/ml mouse CenpE (Santa Cruz Biotechnology, Inc.), 2 µg/ml 
rabbit Nek6 (O’Regan and Fry, 2009), and 1 µg/ml rabbit pHsp70 
(this study). Nek6 antibodies were raised against a peptide correspond-
ing to amino acids 1–15 conjugated to keyhole limpet hemocyanin via 
an N-terminal cysteine (C-MAQPGHMPHGGSSN), whereas Hsp70 anti-
bodies were raised against a phosphopeptide corresponding to amino 
acid residues 60–72 conjugated to ovalbumin via a C-terminal cysteine 
(ALNPQNT(p)VFDAKR-C). Secondary antibodies used were Alexa Fluor 488 
and 594 goat anti–rabbit and goat anti–mouse IgGs (1 µg/ml; Invitrogen). 
(Neckers and Workman, 2012). Hsp90 works in concert with 
Hsp70, and dual depletion of Hsc70 and Hsp72 blocks not only 
Hsp90 function but also the Hsp70-mediated inhibition of apop-
tosis that can otherwise confer resistance to Hsp90 inhibitors 
(Powers et al., 2008). Hence, considerable effort is now being 
put into development of Hsp70 inhibitors (Leu et al., 2009; 
Patury et al., 2009; Massey et al., 2010; Powers et al., 2010; 
Balaburski et al., 2013; Budina-Kolomets et al., 2014). Non–
cancer-derived cells tend to have reduced transcription of Hsp72 
in mitosis (Martínez-Balbás et al., 1995). This results from 
HSF2 (heat shock factor 2) acting as a transcriptional repressor 
in mitosis, blocking expression of Hsp72 by HSF1. However, in 
some cancer cells, HSF2 is repressed in mitosis, allowing HSF1 
to maintain elevated Hsp72 (Elsing et al., 2014). The depen-
dence on Hsp72 that this implies may provide a therapeutic 
window for targeted inhibitors in these cancer types. Hsp72 is 
a novel mitotic substrate of Nek6, and there is growing support 
for Nek6 as an anticancer target (Capra et al., 2006; Chen et al., 
2006; Takeno et al., 2008; Nassirpour et al., 2010). The efficacy 
of Hsp70 inhibitors, both as single agents and in combination 
with Hsp90 or Nek6 inhibitors, will be exciting to test in differ-
ent cancer settings.
Materials and methods
KESTREL analysis
600 confluent 15-cm dishes of HEK 293 cells were collected, washed 
in PBS, and lysed in 50 mM Tris.HCl, pH 7.5, 5% glycerol, 14 mM 
2-mercaptoethanol, 2 mM EDTA, 2 mM EGTA, 10 µg/ml aprotinin, 10 µg/ml 
leupeptin, and 1 mM Pefabloc. Insoluble material was sedimented by cen-
trifugation at 15,000 g for 25 min at 4°C. The supernatant was filtered 
and degassed through a Stericup vacuum filter and then desalted, and 
buffer was exchanged into MOPS–low salt buffer (LSB; 30 mM MOPS, 
pH 7.0, 5% glycerol, 7 mM 2-mercaptoethanol, and 0.03% Brij) by chroma-
tography over a 480-ml Sephadex G-25 fine column. The desalted extract 
was applied to a 25-ml Heparin Sepharose High Performance column. 
The column was washed in 125 ml MOPS-LSB and then eluted over a 
400-ml gradient to 1.2 M NaCl in MOPS-LSB while 40 10-ml fractions 
were collected. 20 µl of each fraction were diluted 1:10 in KESTREL test 
buffer (50 mM Tris.HCl, pH 7.5, 7 mM 2-mercaptoethanol, 1 mM EGTA, 
10 µg/ml leupeptin, and 1 mM Pefabloc) and incubated for 5 min with 
3 mM MnCl2 and 1 kBq/ml -[32P]ATP in the absence or presence of 1 µg/ml 
active recombinant Nek6 (Invitrogen). Reaction products were analyzed 
by SDS-PAGE, transfer to Immobilon P (EMD Millipore), and subsequent 
autoradiography. Heparin Sepharose fractions 16–18 contained potential 
Nek6 substrates and so were pooled, desalted, separated along a 10-ml 
gradient to 1 M NaCl on a 1-ml Source 15Q column, and analyzed for po-
tential Nek6 substrates as described in the previous paragraph. Substrate 
containing Source 15Q fractions 16–18 were pooled, separated by size 
using a 120 ml Superdex 200 column, and analyzed as in this paragraph. 
Superdex 200 fractions 3–7 were pooled, concentrated by filtration, and 
incubated with either 3 mM MnCl2 or 10 mM Mg-acetate in the presence 
of -[32P]ATP, with or without 1 µg/ml Nek6. The reactions were denatured, 
alkylated with 50 mM iodoacetamide, and separated by SDS-PAGE, and the 
gels were stained with colloidal Coomassie (Invitrogen) and subsequently 
analyzed by autoradiography. Protein bands that were visible with Coo-
massie staining and had been radiolabeled in the presence of Nek6 were ex-
cised from the gels, destained, digested with trypsin, and subjected to mass 
spectrometry fingerprinting (matrix-assisted laser desorption/ionization– 
tandem time of flight) using a proteomics analyzer (4700; Applied Biosys-
tems) for data acquisition and the Mascot search engine (Matrix Science) 
to search for matches in the NCBInr database.
Plasmid construction, mutagenesis, and recombinant protein expression
Full-length cDNAs expressing human Hsp72 and Hsc70, provided by 
R. van Monfort (Institute of Cancer Research, Sutton, England, UK), were 
amplified by PCR and inserted into pLEICS-12 for expression with an 
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(O’Regan and Fry, 2009), 0.3 µg/ml mouse -tubulin (Sigma-Aldrich), 
0.5 µg/ml mouse Flag (Sigma-Aldrich), 0.5 µg/ml mouse Hsp70 (Santa 
Cruz Biotechnology, Inc.), 0.5 µg/ml mouse Hsp72 (Enzo Life Sciences), 
0.5 µg/ml mouse Hsc70 (Santa Cruz Biotechnology, Inc.), 1 µg/ml rabbit 
pHsp70 (this study), 0.8 µg/ml goat Nek9 (Santa Cruz Biotechnology, 
Inc.), 1 µg/ml rabbit GAPDH (Cell Signaling Technology), 1 µg/ml mouse 
phospho–histone H3 (EMD Millipore), 0.2 µg/ml rabbit -tubulin (Sigma-
Aldrich), 0.4 µg/ml mouse TACC3 (Abcam), 0.5 µg/ml rabbit ch-TOG 
(Bethyl Laboratories, Inc.), and 1 µg/ml mouse Cep55 (Santa Cruz Bio-
technology, Inc.). Nek7 antibodies were raised against a peptide cor-
responding to amino acid residues 12–28 conjugated to keyhole limpet 
hemocyanin via an N-terminal cysteine (C-OVPQFQPQKALRPDM). Sec-
ondary antibodies were HRP-labeled anti–mouse, anti–rabbit, or anti–goat 
IgGs (1:1,000; Sigma-Aldrich) or alkaline phosphatase–conjugated IgGs 
(1:7,500; Promega). HRP-labeled blots were detected by enhanced chemi-
luminescence (Thermo Fisher Scientific).
Statistical analysis
All quantitative data represent means and SD of at least three indepen-
dent experiments. Statistical analyses were performed using a one-tailed 
unpaired Student’s t test assuming unequal variance, a one-way analysis 
of variance followed by post hoc testing or an 2 test, as appropriate. 
P-values represent *, P < 0.05; **, P < 0.01; ***, P < 0.001. For box and 
whisker plots, boxes represent the 25th and 75th percentile, the green and 
white lines represent the medians and means, respectively, and whiskers 
show the 10th and 90th percentile.
Online supplemental material
Fig. S1 shows purification of Nek6 substrates from HEK293 extracts using 
the KESTREL strategy. Fig. S2 shows additional data relating to mitotic phe-
notypes associated with loss of Hsp72 activity. Fig. S3 shows mapping of 
the Nek6 phosphorylation site on Hsp72 and the validation of Hsp72pT66 
antibody specificity when used for immunofluorescence (IF). Videos 1–3 
show time-lapse imaging of chromosome congression in control, Hsp72-
depleted, and Hsp70i-treated cells, respectively. Videos 4 and 5 show 
time-lapse imaging of metaphase chromosome alignment in DMSO- or 
Hsp70i-treated cells, respectively. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201409151/DC1.
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